In Vitro Effects of Weissella cibaria CMU and CMS1 on Receptor Activator of NF-κB Ligand (RANKL)-Induced Osteoclast Differentiation
Source abstract
Abstract
Excessive osteoclast activity can promote periodontitis-associated bone destruction. The inhibitory mechanisms of Weissella cibaria strains CMU and CMS1 against periodontitis have not yet been fully elucidated. In this study, we aimed to investigate whether heat-killed (HK) W. cibaria CMU and CMS1 or their respective cell-free supernatants (CFSs) inhibit osteoclast differentiation and bone resorption in response to receptor activator of nuclear factor kappa-B ligand (RANKL)-treated RAW 264.7 cells. TRAP (tartrate-resistant acid phosphatase) staining and bone resorption assays revealed that both HK bacteria and CFSs significantly suppressed the number of TRAP-positive cells, TRAP activity, and bone pit formation compared to the RANKL-treated control (p < 0.05). HK bacteria dose-dependently inhibited osteoclastogenesis while selectively regulating certain genes in CFSs (p < 0.05). We found that disrupting the direct interaction between HK bacteria and RAW 264.7 cells abolished the inhibitory effect of HK bacteria on the expression of osteoclastogenesis-associated proteins (c-Fos, nuclear factor of activated T cells c1 (NFATc1), and cathepsin K). These results suggest that dead bacteria suppress osteoclast differentiation more effectively than the metabolites and may serve as beneficial agents in preventing periodontitis by inhibiting osteoclast differentiation via direct interaction with cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Oral microbiology and periodontitis research · Bone Metabolism and Diseases · Osteomyelitis and Bone Disorders Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
R&D Center, OraTicx, Inc., Seoul 04782, Republic of Korea
Funding
Ministry of Small and Medium Enterprises (SMEs) and Startups (MSS, Republic of Korea)
References (39)
Show source-provided references
1. Prevalence of periodontal disease, its association with systemic diseases and prevention
2. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression10.1177/0022034514552491 ↗
3. Inflammasomes in alveolar bone loss10.3389/fimmu.2021.691013 ↗
4. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems10.1038/nri2062 ↗
5. The cell biology of bone metabolism10.1136/jcp.2007.048868 ↗
6. Bone resorption activity in mature osteoclasts10.1007/978-1-4939-8802-0_22 ↗
7. RANKL-RANK signaling in osteoclastogenesis and bone disease10.1016/j.molmed.2005.11.007 ↗
8. Magnolol inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression10.1021/np500663y ↗
9. Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF-κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis10.3892/ijmm.2021.5059 ↗
10. Cathepsin K localizes to equine bone in vivo and inhibits bone marrow stem and progenitor cells differentiation in vitro10.46582/jsrm.1302008 ↗
11. Bee venom attenuates Porphyromonas gingivalis and RANKL-induced bone resorption with osteoclastogenic differentiation10.1016/j.fct.2019.05.001 ↗
12. Cheng, Y., Liu, H., Li, J., Ma, Y., Song, C., Wang, Y., Li, P., Chen, Y., and Zhang, Z. (2022). Evaluation of culture conditions for osteoclastogenesis in RAW264.7 cells. PLoS ONE, 17.10.1371/journal.pone.0277871 ↗
13. Effect of menaquinone-4 on receptor activator of nuclear factor κB ligand-induced osteoclast differentiation and ovariectomy-induced bone loss
14. Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms10.1016/j.job.2020.02.002 ↗
15. Maintaining homeostatic control of periodontal bone tissue10.1111/prd.12368 ↗
16. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss10.1111/jre.12164 ↗
17. Benefits of Bifidobacterium animalis subsp. lactis probiotic in experimental periodontitis10.1902/jop.2016.160217 ↗
18. Effect of Weissella cibaria on the reduction of periodontal tissue destruction in mice10.1002/JPER.19-0288 ↗
19. Kang, M.S., Yeu, J.E., and Hong, S.P. (2019). Safety Evaluation of oral care probiotics Weissella cibaria CMU and CMS1 by phenotypic and genotypic analysis. Int. J. Mol. Sci., 20.10.3390/ijms20112693 ↗
20. Weissella cibaria CMU exerts an anti-inflammatory effect by inhibiting Aggregatibacter actinomycetemcomitans-induced NF-κB activation in macrophages
21. Kang, M.S., Lee, D.S., Lee, S.A., Kim, M.S., and Nam, S.H. (2020). Effects of probiotic bacterium Weissella cibaria CMU on periodontal health and microbiota: A randomised, double-blind, placebo-controlled trial. BMC Oral Health, 20.10.1186/s12903-020-01231-2 ↗
22. Kang, M.S., Park, G.Y., and Lee, A.R. (2023). In vitro preventive effect and mechanism of action of Weissella cibaria CMU against Streptococcus mutans biofilm formation and periodontal pathogens. Microorganisms, 11.10.3390/microorganisms11040962 ↗
23. Liu, T.H., Tsai, T.Y., and Pan, T.M. (2018). The anti-periodontitis effects of ethanol extract prepared using Lactobacillus paracasei subsp. paracasei NTU 101. Nutrients, 10.10.3390/nu10040472 ↗
24. Characterizing how probiotic Lactobacillus reuteri 6475 and lactobacillic acid mediate suppression of osteoclast differentiation10.1016/j.bonr.2019.100227 ↗
25. Jung, J.I., Baek, S.M., Nguyen, T.H., Kim, J.W., Kang, C.H., Kim, S., and Imm, J.Y. (2021). Effects of probiotic culture supernatant on cariogenic biofilm formation and RANKL-induced osteoclastogenesis in RAW 264.7 macrophages. Molecules, 26.10.3390/molecules26030733 ↗
26. Oral administration of Lactobacillus gasseri SBT2055 is effective in preventing Porphyromonas gingivalis-accelerated periodontal disease10.1038/s41598-017-00623-9 ↗
27. Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis10.1111/jcpe.12838 ↗
28. Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats10.1371/journal.pone.0179946 ↗
29. Vaspin attenuates RANKL-induced osteoclast formation in RAW264.7 cells10.3109/03008207.2012.761978 ↗
30. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells10.1002/jcp.27852 ↗
31. Effect of the probiotic Saccharomyces cerevisiae on ligature-induced periodontitis in rats10.1111/jre.12274 ↗
32. Favourable effects of Bacillus subtilis and Bacillus licheniformis on experimental periodontitis in rats10.1016/j.archoralbio.2016.02.014 ↗
33. Food and Agricultural Organization of the United Nation and the WHO. The importance of guidelines in the development and application of probiotics10.2174/1381612053382395 ↗
34. Probiotic use in clinical practice: What are the risks?10.1093/ajcn/83.6.1256 ↗
35. Deshpande, G., Athalye-Jape, G., and Patole, S. (2018). Para-probiotics for preterm neonates-The next frontier. Nutrients, 10.10.3390/nu10070871 ↗
36. Piqué, N., Berlanga, M., and Miñana-Galbis, D. (2019). Health benefits of heat-killed (tyndallized) probiotics: An overview. Int. J. Mol. Sci., 20.10.3390/ijms20102534 ↗
37. Paraprobiotics and postbiotics of probiotic Lactobacilli, their positive effects on the host and action mechanisms: A review10.3389/fnut.2020.570344 ↗
38. Effects of Lactobacillus reuteri MG5346 on receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis and ligature-induced experimental periodontitis rats10.5851/kosfa.2022.e68 ↗
39. Tartrate-resistant acid phosphate activity as osteoclastic marker: Sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry10.1007/BF01623458 ↗